Related Experiment Video

Updated: Jun 26, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

New developments in targeted molecular therapies for glioblastoma

Patrick Y Wen

    Expert Review of Anticancer Therapy
    |December 25, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
    11:15

    Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

    Published on: September 1, 2018

    Related Experiment Videos

    Last Updated: Jun 26, 2026

    Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
    09:02

    Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

    Published on: September 27, 2024

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
    11:15

    Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

    Published on: September 1, 2018

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Insulin feedback is a targetable resistance mechanism of PI3K inhibition in glioblastoma.

    Neuro-oncology·2023

    Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2023

    Understanding the patient experience and treatment benefits in patients with non-small-cell lung cancer with brain metastasis.

    Cancer medicine·2023

    Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419).

    European journal of cancer (Oxford, England : 1990)·2023

    Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.

    The New England journal of medicine·2023

    Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results.

    Nature medicine·2023

    From fragmentation to focus: building collaborative networks for rare cancer research - the Italian TYME network as a model for care and innovation?

    Expert review of anticancer therapy·2026

    Conversion surgery for advanced biliary tract cancer in the era of molecularly targeted therapy and immunotherapy: from unresectable disease to multidisciplinary curative strategy.

    Expert review of anticancer therapy·2026

    AA amyloidosis as a renal immune-related adverse event of immune checkpoint inhibitors: mechanisms, diagnosis, and management.

    Expert review of anticancer therapy·2026

    Angiosarcoma: adaptive designs leveraging vascular biology and antiangiogenic repurposing.

    Expert review of anticancer therapy·2026

    The transcriptional landscape in thyroid cancer: current status of circulating biomarkers and liquid biopsy approaches.

    Expert review of anticancer therapy·2026

    Portal vein resection in pancreatic cancer: from technical feasibility to biological patient selection.

    Expert review of anticancer therapy·2026

    Assessment of Natural Killer Cell Serial Degranulation.

    Current protocols·2026

    Oncogenic KRAS Rewires mRNA Stability and Translation through AGO2-Mediated Disruption of the miRNA pathway.

    Cancer research·2026

    Stimuli-responsive nanocarriers for precision cation channel therapy.

    Chemical communications (Cambridge, England)·2026

    Disruption of hippocampal upstream regulators of mTOR and insulin pathways in Down syndrome with Alzheimer's disease neuropathology: Preliminary observations.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

    ATF7 drives diabetic wound healing via NOTCH1 repression and N1ICD-dependent macrophage polarization control.

    JCI insight·2026

    Innate immune sensor NOD2 promotes cartilage degradation and osteoarthritis progression by stabilizing TRAF6 in chondrocytes.

    JCI insight·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us